KMDA
Price
$7.06
Change
-$0.35 (-4.72%)
Updated
Mar 10, 04:59 PM (EDT)
Capitalization
306.49M
77 days until earnings call
NXSCF
Price
$0.07
Change
-$0.02 (-22.22%)
Updated
Mar 3 closing price
Capitalization
82.26M
Ad is loading...

KMDA vs NXSCF

Header iconKMDA vs NXSCF Comparison
Open Charts KMDA vs NXSCFBanner chart's image
Kamada
Price$7.06
Change-$0.35 (-4.72%)
Volume$700
Capitalization306.49M
NEXT SCIENCE
Price$0.07
Change-$0.02 (-22.22%)
Volume$12K
Capitalization82.26M
KMDA vs NXSCF Comparison Chart
Loading...
KMDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KMDA vs. NXSCF commentary
Mar 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KMDA is a Hold and NXSCF is a Hold.

Ad is loading...
COMPARISON
Comparison
Mar 11, 2025
Stock price -- (KMDA: $7.41 vs. NXSCF: $0.07)
Brand notoriety: KMDA and NXSCF are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: KMDA: 101% vs. NXSCF: 187%
Market capitalization -- KMDA: $306.49M vs. NXSCF: $82.26M
KMDA [@Pharmaceuticals: Other] is valued at $306.49M. NXSCF’s [@Pharmaceuticals: Other] market capitalization is $82.26M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KMDA’s FA Score shows that 0 FA rating(s) are green whileNXSCF’s FA Score has 0 green FA rating(s).

  • KMDA’s FA Score: 0 green, 5 red.
  • NXSCF’s FA Score: 0 green, 5 red.
According to our system of comparison, KMDA is a better buy in the long-term than NXSCF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KMDA’s TA Score shows that 4 TA indicator(s) are bullish.

  • KMDA’s TA Score: 4 bullish, 5 bearish.

Price Growth

KMDA (@Pharmaceuticals: Other) experienced а +7.55% price change this week, while NXSCF (@Pharmaceuticals: Other) price change was -17.65% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.33%. For the same industry, the average monthly price growth was -2.66%, and the average quarterly price growth was -1.58%.

Reported Earning Dates

KMDA is expected to report earnings on May 27, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-1.33% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KMDA($306M) has a higher market cap than NXSCF($82.3M). KMDA YTD gains are higher at: 21.675 vs. NXSCF (0.000). KMDA has higher annual earnings (EBITDA): 22.4M vs. NXSCF (-11.94M). KMDA has more cash in the bank: 55.6M vs. NXSCF (7.37M). NXSCF has less debt than KMDA: NXSCF (276K) vs KMDA (8.82M). KMDA has higher revenues than NXSCF: KMDA (143M) vs NXSCF (10.4M).
KMDANXSCFKMDA / NXSCF
Capitalization306M82.3M372%
EBITDA22.4M-11.94M-188%
Gain YTD21.6750.000-
P/E Ratio37.43N/A-
Revenue143M10.4M1,375%
Total Cash55.6M7.37M755%
Total Debt8.82M276K3,196%
FUNDAMENTALS RATINGS
KMDA: Fundamental Ratings
KMDA
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
PROFIT vs RISK RATING
1..100
94
SMR RATING
1..100
76
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
84
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KMDA
RSI
ODDS (%)
Bearish Trend 4 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
65%
Momentum
ODDS (%)
Bearish Trend 4 days ago
65%
MACD
ODDS (%)
Bearish Trend 4 days ago
66%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
66%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
73%
Advances
ODDS (%)
Bullish Trend 4 days ago
70%
Declines
ODDS (%)
Bearish Trend 7 days ago
65%
BollingerBands
ODDS (%)
N/A
Aroon
ODDS (%)
Bullish Trend 4 days ago
57%
View a ticker or compare two or three
Ad is loading...
KMDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ENPH61.632.91
+4.96%
Enphase Energy
EVGN1.480.07
+4.94%
Evogene Ltd.
USM65.090.56
+0.87%
United States Cellular Corp
PVBC11.53-0.19
-1.62%
Provident Bancorp
CATX2.61-0.09
-3.33%
Perspective Therapeutics

KMDA and

Correlation & Price change

A.I.dvisor tells us that KMDA and INCR have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KMDA and INCR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KMDA
1D Price
Change %
KMDA100%
+1.23%
INCR - KMDA
29%
Poorly correlated
+1.25%
NXSCF - KMDA
27%
Poorly correlated
N/A
SGIOY - KMDA
27%
Poorly correlated
+0.52%
RDY - KMDA
25%
Poorly correlated
-0.62%
ACET - KMDA
22%
Poorly correlated
-5.90%
More

NXSCF and

Correlation & Price change

A.I.dvisor tells us that NXSCF and KMDA have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NXSCF and KMDA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NXSCF
1D Price
Change %
NXSCF100%
N/A
KMDA - NXSCF
27%
Poorly correlated
+1.23%
APNHY - NXSCF
20%
Poorly correlated
-1.67%
MVMDF - NXSCF
12%
Poorly correlated
+7.86%
OMID - NXSCF
6%
Poorly correlated
N/A
MRMD - NXSCF
5%
Poorly correlated
-0.46%
More